Gynecologic Oncology
|
|
- Rodger Mitchell
- 6 years ago
- Views:
Transcription
1 Gynecologic Oncology 127 (2012) Contents lists available at SciVerse ScienceDirect Gynecologic Oncology journal homepage: Would complex decongestive therapy reveal long term effect and lymphoscintigraphy predict the outcome of lower-limb lymphedema related to gynecologic cancer treatment? Young Bum Kim a, Ji Hye Hwang b,, Tae Won Kim b, Hyun Ju Chang b, Sang Gil Lee b a Department of Rehabilitation Medicine, Pusan National University Yangsan Hospital, Pusan, , Republic of Korea b Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul , Republic of Korea HIGHLIGHTS The edema reducing effects of CDT are better maintained in the distal leg than in the proximal part. Initial lymphoscintigraphic quantitative finding may usefully predict the short and long-term response to CDT. article info abstract Article history: Received 23 May 2012 Accepted 15 September 2012 Available online 26 September 2012 Keywords: Lymphedema Complex decongestive therapy Lymphoscintigraphy Gynecological cancer Objective. The aims of this study were to investigate the long-term effect of complex decongestive therapy (CDT) on lymphedema volume reduction, especially considering the proximal and distal parts of the leg, and to evaluate the utility of pre-therapy lymphoscintigraphy in predicting the response to CDT in patients with lower-limb lymphedema after surgery for gynecologic cancer. Methods. Medical records of 158 patients with secondary lymphedema of unilateral leg after surgery for gynecological cancer were reviewed retrospectively. They were treated with two weeks of CDT along with self-administered home therapy and were followed up for 24 months. Whole, proximal and distal leg volume was serially measured by using an optoelectric volumeter prior to and immediately after therapy, and follow-up visits at months 3, 6, 12 and 24. Lymphoscintigraphy was performed prior to therapy. Results. The percent volume reduction was 22.1% in the whole leg, 30.9% in the distal leg and 18.4% in the proximal leg immediately after CDT. The volume reduction was maintained for 24 months, but the distal leg was significantly well maintained better than the proximal leg. Extremity radioisotope uptake ratio (EUR) among lymphoscintigraphic findings could predict the improvement of lymphedema volume in the distal, proximal and whole leg. Conclusions. This study suggests that the long-term edema reducing effects of CDT are better maintained in the distal leg than in the proximal part, and initial lymphoscintigraphic quantitative finding may usefully predict the short and long-term response to CDT. Crown Copyright 2012 Published by Elsevier Inc. All rights reserved. Introduction Chronic lymphedema that arises as a consequence of impaired lymphatic drainage causes symptomatic, functional and aesthetic defects as well as psychological sequelae, thereby reducing the quality of life for gynecological cancer survivors [1 3]. The reported frequency of lower limb lymphedema secondary to treatment of gynecological cancers ranges from 10% to 49% [4,5]. Upper-limb lymphedema is a frequent complication following breast cancer treatment with estimated frequency of 12% 28% [6 8]. Recently Corresponding author. Fax: address: hwanglee@skku.edu (J.H. Hwang). sentinel lymph node biopsy (SLNB) reduces the incidence of lymphedema compared with axillary lymph node dissection (ALND) in patients with breast cancer. One study reported that lymphedema was found in 5% of patients who underwent SLNB alone and 16% of patients who underwent SLNB/ALND [9]. In the treatment of gynecologic cancers (cervical cancer, endometrial cancer, ovarian cancer etc.), knowledge on lymph node metastatic pathways and mechanism has emphasized the need for radical lymph node dissection and adjuvant radiotherapy. And unlike the treatment of breast cancer, clinical studies on SLNB in gynecologic cancer continue to be conducted, so it is limited for SLNB to be widely applied in clinical area. The above reasons can make a difference of lymphedema frequency between breast cancer and gynecologic cancer patients /$ see front matter. Crown Copyright 2012 Published by Elsevier Inc. All rights reserved.
2 Y.B. Kim et al. / Gynecologic Oncology 127 (2012) The affected patient with lower-limb lymphedema can experience pain, swelling of the leg with increased dermal turgor and hyperkeratosis, tightness and heaviness in the leg and recurrent skin infections, so the patient has problems with walking, running, and fitting shoes. When combined with genital lymphedema, patients can be devastated. These problems tend to be worse in the patients with lower limb lymphedema than upper limb lymphedema when considering our clinical experience and ongoing research. Current management of lymphedema is based on complex decongestive therapy (CDT), and it includes manual lymph drainages, low-stretch bandaging, exercises and skin care. There are many studies to describe the effect of CDT in patients with upper limb lymphedema after breast cancer treatment [10 13], but there has been limited study of lower-limb lymphedema after CDT. While some studies have reported a reduction in edema after CDT during the first 12 months or less following cancer treatment [12,14], little is known regarding the long-term edema reducing effect of CDT in lower-limb lymphedema. Conventional treatment such as sequential pneumatic compression pump reduces edema volume of the distal leg well, but greatly reduces the degree of edema reduction or rather increases edema volume in the proximal leg because it let edema fluid translocate to the proximal territory [12,14]. In contrast, CDT has been suggested to make little difference in the volume reducing effect of CDT between the proximal and distal legs because it reflects more normal physiologic mechanism in the way that improves the functionality of the remaining lymphatic system. But, maintenance effect of longterm follow up is not known. Therefore, in this study, lower limb was divided into the proximal and distal legs, and we investigated the difference between them. The response to CDT is not uniform in patients with secondary lymphedema of the lower-limbs. One study reported that age, lymphedema duration, and radiotherapy did not affect lymphedema severity and CDT efficacy, but factors such as lymphoscintigraphy findings that influence the outcome of therapy have not yet received sufficient study [14]. Lymphoscintigraphy offers objective evidence to distinguish lymphatic pathology from non-lymphatic causes of extremity edema [15 17]. Qualitative and quantitative lymphoscintigraphies has been widely used in the assessment of therapeutic interventions for lymphedema, ranging from microsurgery and liposuction to manual lymphatic massage, and pneumatic compression [18 22], and it may predict the outcome of lymphedema therapy. In a recent study of women undergoing therapy for post-mastectomy lymphedema, Szuba et al. found that the degree of lymphatic function impairment before treatment correlated with the outcome of manual lymphatic therapy [23]. Also, Hwang et al. suggested that qualitative lymphoscintigraphy is potentially useful for predicting the response of patients with early unilateral leg lymphedema to CDT [12]. However, there has been no study analyzing the relationship between the quantitative findings of lymphoscintigraphy and the edema reducing effect of CDT for lower-limb lymphedema. Therefore, the purpose of this study was to investigate the longterm edema reducing effect of CDT especially considering the proximal and distal parts of the leg separately and to evaluate the utility of pre-therapy lymphoscintigraphy in predicting the response to CDT in patients with lower-limb lymphedema. Methods Patients A retrospective chart review was performed for 273 patients treated for lower-limb lymphedema between 1 January 2000 and 30 October The inclusion criteria for this study were as follows: 1) unilateral lower-limb lymphedema after surgery for gynecological cancer of clinical stage II (spontaneously irreversible non-pitting edema) or III (lymphostatic elephantiasis) diagnosed based on clinical assessment and lymphoscintigraphic findings; 2) fully attended decongestive treatment five times per week for two weeks once over follow up period; and 3) clinical follow-up longer than two years after CDT. The exclusion criteria were as follows 1) cancer recurrence during follow-up; 2) combined vascular disease of the extremities (arterial insufficiency, deep vein thrombosis, chronic venous insufficiency); 3) past history of attempted lymphedema reduction by any method; and 4) heart or kidney disease. One hundred and fifteen patients were excluded for primary lymphedema, bilateral lymphedema, or non-gynecological cancer. Therefore, 158 patients were enrolled in this study. A chart review was undertaken to obtain the following clinical information: patient age, body mass index, cancer related therapy (chemotherapy and radiotherapy), infection of the lower limb(s), age of onset, period from surgery to lymphedema onset, lymphoscintigraphy findings, and lymphedema volume. This study was approved by governing Institutional Review Board (IRB) of our hospital. Complex decongestive therapy CDT was divided into two phases consisted of decongestive phase and maintenance phase. In decongestive phase, two certified skilled physical therapists performed the 2-week CDT program which included 1 hour of manual lymphatic drainage (MLD), multilayered and low-strech compressive bandages and specific remedial exercises for five times per week. After 2 weeks of decongestive phase, patients followed the maintenance program. The at-home maintenance therapy consisted of high pressure compression stocking worn during the day, a daily session of self-administered MLD, and skin care as well as exercise programs. Additionally, it was recommended that at least three bandages be worn during the nighttime per week. During the maintenance phase, follow-up visits were scheduled at 3, 6, 12 and 24 months post-cdt. At each follow-up visit, we measured lymphedema volume and checked self-control activities for compliance of patients. Lymphoscintigraphy Lymphoscintigraphy was performed prior to the institution of therapeutic interventions for lymphedema. One hundred and forty-eight MBq 99m Tc-filtered phytate colloid (total 3 mci) was administered subcutaneously on the dorsum of the both feet in the inter-digital spaces using a 27-gauge needle. The patient performed a stress activity of walking for 30 minutes after injection, and then the imaging was repeated. Static images were obtained immediately after exercise and one and two hours after injection. The uptake percentages of the radioisotope in the inguinal lymph nodes and the extremity in question, in addition to the clearance from the injection site on the feet were measured with the gamma camera. Both qualitative and quantitative parameters were measured, including the inguinal lymph node radioisotope uptake ratio (IUR), extremity radioisotope uptake ratio (EUR), and the radioisotope clearance ratio (CR). The IUR was established by placing symmetrical regions of interest (ROIs) over the groin on each lymphoscintigraph. The counts in each ROI were measured, and the ratio of the affected to the non-affected side was calculated for each patient. The analysis was performed using static images 2 h after injection of the radiotracer. The EUR was measured by placing the symmetrical ROIs below the groin lymph node and above the injection site on each lymphoscintigraph. ThecountsineachROIweremeasured, and the ratio of the affected to the non-affected side was calculated for each patient. The analysis was performed using static images 2 h after injection of the radiotracer. The CR was measured by placing the symmetrical ROIs on the radiotracer injection site on the feet. The counts in each ROI were measured, and the ratio of the affected to the non-affected side was
3 640 Y.B. Kim et al. / Gynecologic Oncology 127 (2012) calculated for each patient. The analysis was performed using static images 2 h after injection of the radiotracer. Limb volume measures Limb volume was serially measured using an optoelectric volumeter (Perometer, Pero-system; Wuppertal, Germany). An attempt was made to obtain two measures from the same site and these measurements were averaged. In addition to whole leg volume, we also measured the volume of the proximal portion of the leg (above knee) and the distal portion of the leg (below knee). Measurements were taken by a physical therapist experienced in lymphedema treatment before CDT (baseline), immediately after CDT, and at months 3, 6, 12, and 24 after CDT. In calculations of limb volume reduction, the unaffected limb was used as a normal control for the affected limb (% excess volume). Limb volume reduction was calculated using the following formula: % excess volume ¼ ½ðVa VuÞ=VuŠ100; where Va is the volume (ml) of the affected lower-limb, and Vu is the volume (ml) of the unaffected lower-limb. The outcome of CDT was quantified as the difference between the affected lower-limb volumes before and after therapy, and the percent reduction in lower-limb volume was calculated using the following formula: % volume reduction ¼ ½ðpreV postvþ=prevš100; where prev is the percent excess volume of the affected lower limb prior to CDT, and postv is the percent excess volume of the affected lower-limb after CDT. Statistical analysis All variables were tested for normality using the one-sample Kolmogorov Smirnov test and all variables a normal distribution. The paired t-test was used to detect the significant effects of CDT on lymphedema before CDT (baseline), right after CDT, and at months 3, 6, 12, and 24 after CDT. Spearman's rank correlation coefficient analysis was used to assess correlations between the lymphoscintigraphic findings (IUR, EUR, CR) and the clinical volume measures. To find the prognostic factor of lymphoscintigraphy for predicting the outcome of CDT, multiple logistic regression analysis was adopted for the statistical analysis. The results were presented as means with standard deviations. P-values less than 0.05 were considered as statistically significant. The collected data were analyzed using SPSS version 18.0 (SPSS, Inc., Chicago, USA). Results Descriptive characteristics Table 1 shows the patients' characteristics at inclusion. A total of 158 women with an average age of 53.0±11.2 years were included in our study. Body mass index ranged from 19.8 to 40.1 (mean=25.9; SD=4.7). Among these patients, 89 patients (55.8%) had lymphedema of left leg and 69 lymphedema of right leg. When the patients classified according to primary cancer sites, cervical cancer (71.1%) was the most. With regard to their cancer-related treatment, all patients had surgery, 63 patients (38.6%) underwent chemotherapy, and 78 patients (47.8%) received radiotherapy. The length of time between surgery and the onset of lymphedema varied from 1.0 to months (mean=55.3; SD=57.6). Table 1 Patient characteristics at inclusion (before CDPT) (n=158). Characteristic Study group Age (years) Mean (SD) 53.0 (11.2) Range Body mass index (kg/m 2 ) Mean (SD) 25.9 (4.7) Range Site of lymphedema (n) Right 69 Left 89 Site of cancer (n) Cervix 116 Uterus 23 Ovary 18 Liposarcoma 1 Cancer-related treatment (n) Surgery 158 Chemotherapy 63 Radiotherapy 78 Lymphedema onset delay since surgery (months) Mean (SD) 55.3 (57.6) Range Edema reduction When compared to the unaffected leg, data for the mean percent excess volume difference of the affected proximal leg, distal leg, and whole leg pre-cdt, immediately after CDT, and 3, 6, 12, and 24 months post-cdt are shown in Table 2. The percent excess volume in the distal leg and whole leg immediately after CDT, and at 3, 6, 12, and 24 months post-cdt was significantly lower than at baseline (Pb0.01; Fig. 1), but no significant difference was seen at 12 and 24 months in the proximal leg (Fig. 2). This result indicated that the percent excess volume tends to increase with time after CDT in the proximal leg, distal leg, and whole leg. The mean percent volume reduction of the affected leg at 3, 6, 12, and 24 months post-cdt was shown in Table 3 when compared with the pre-cdt volume. Quantitative lymphoscintigraphy There was a significant negative correlation between the IUR and the percent excess volume in the proximal leg, distal leg, and whole leg in pre-cdt. The outcome of CDT (quantified as the percent volume reduction compared to the pre-cdt percent excess volume) negatively correlated with the IUR in the distal leg and whole leg immediately after CDT and at 3 and 6 months post-cdt, but not with the IUR of the proximal leg at any of the follow-up times. There was a significant positive correlation between the EUR and percent excess volume in the proximal leg, distal leg, and whole leg, pre-cdt. The EUR correlated positively with the percent volume reduction in the distal leg immediately after CDT and at 3, 6, 12 and 24 months post-cdt, and in the whole leg at 3 and 6 months post-cdt, but not with the percent volume reduction in the proximal leg at any of the follow-up times. No correlation was observed between CR and the percent volume reduction in the distal leg, proximal leg, or whole leg at any of the follow-up times. Multiple linear regression analysis revealed that EUR Table 2 Percent excess volume of affected lower limb. Time Proximal leg Distal leg Whole leg Pre-CDT 31.6±29.6% 32.4±39.1% 31.5±29.7% Post-CDT 27.8±25.6% 22.6±30.3% 24.0±24.1% 3 months 24.6±24.3% 22.2±27.8% 22.9±22.5% 6 months 25.3±21.8% 23.1±26.8% 23.7±21.5% 12 months 29.5±25.3%, 23.7±30.7%, 26.0±24.4%, 24 months 31.0±23.8%, 24.7±30.0%, 26.8±21.6%,
4 Y.B. Kim et al. / Gynecologic Oncology 127 (2012) Table 3 Percent volume reduction of affected lower limb after CDT compared to before CDT. Time Proximal leg Distal leg Whole leg Post-CDT 18.4±14.3% 30.9±38.4% 22.1±28.6% 3 months 21.0±28.6% 34.2±29.1% 22.1±24.9% 6 months 20.1±34.5% 35.8±33.1% 27.3±23.8% 12 months 9.5±17.5% 25.2±21.0% 19.7±17.2% 24 months 10.3±24.8% 16.9±22.8% 16.3±19.5% Pb0.05, Pb0.01. Fig. 1. Percent excess volume of the proximal portion of the affected lower limb compared to that of the unaffected lower limb. could predict the improvement of lymphedema volume in the distal leg and proximal leg immediately after CDT and at 3, 6 and 12 months post-cdt, and in the whole leg immediately after CDT and at 3, 6, 12 and 24 months post-cdt, but IUR and CR couldn't predict that in the distal leg, proximal leg, or whole leg at any of the follow-up times. Discussion This is the first study to investigate the long-term effect of CDT in the lower leg divided into the proximal and distal portions and analyze quantitative lymphoscintigraphy to predict the outcome of CDT in lower-limb lymphedema following surgery for gynecological cancer. In this study, changes in lower-limb volume reduction were compared with the subjects' normal lower-limb as a control for their affected lower-limb. Our results show that percent reduction volume was 22.1±28.6% immediately post-cdt, 27.4±24.9% 3 months post-cdt, 24.7±23.8% 6 months post-cdt, 19.7±17.2% 12 months post-cdt, and 16.3±19.5% 24 months post-cdt in the whole leg, and the greatest decrease in lymphedema volume was at 3 months after CDT, with lymphedema volume tending to increase over time thereafter. It is pointed out that CDT can make little difference in the volume reducing effect of CDT between the proximal and distal legs rather than the effect of sequential pneumatic compression pump. In our Fig. 2. Percent excess volume of the distal portion of the affected lower limb compared to that of the unaffected lower limb. results, the percent excess volume pre-cdt, immediately post-cdt, and at 3, 6, 12, and 24 months post-cdt was significantly lower than at baseline for the distal leg and whole leg (Pb0.01), but there was no significant difference between the percent excess volume pre-cdt and at 12 and 24 months post-cdt in the proximal leg. An important finding in our study is that there was no significant difference in the percent excess volume at 12 and 24 months compared to that pre-cdt for the proximal leg, indicating that the management of lower-limb lymphedema for the proximal portion of the leg is more difficult than the distal portion. Therefore, we recommend paying more attention to the management of proximal leg lymphedema. The results of this study correspond with the results of earlier studies. They reported a variety of percent lymphedema volume reduction, and this difference may be related to patient factors (different clinical stage of lymphedema, compliance), therapy factors (skill of the therapist, therapy time and duration), and differing formulas used for limb volume calculation [24 27]. One study reported that compliance of patients has an influence on the persistence of reduced lymphedema volume [28]. Foldi et al. found that the initial reduction in lymphedema obtained after the decongestive phase was maintained in more than 50% of the patients maintained during a three-year follow-up program [24]. Lymphoscintigraphy is a noninvasive, effective and safe technique to determine the functional status of peripheral lymphatic vessels, and now has been advocated as the preferred diagnostic test for peripheral lymphedema [17,29,30]. Criteria defining lymphatic dysfunction include delay, asymmetric or absent visualization of regional lymph nodes, and the presence of dermal backflow. Additional findings include visualization of asymmetric lymphatic channels, collateral lymphatic channels, interrupted vascular structures, and lymph nodes of the deep lymphatic system (i.e., popliteal lymph nodes after web space injection in the lower extremities) [15]. Quantitative analysis may increase the sensitivity and specificity of lymphoscintigraphy in the diagnosis of lymphatic disorders [17]. The protocol for lymphoscintigraphy is not standardized and differs among diagnostic centers. Differences include the choice of radiotracer, the type and site of injection, the use of dynamic and static acquisitions, and the acquisition times themselves. In this study, there was a significant, negative correlation between the IUR and percent excess volume in the proximal leg, distal leg, and whole leg, pre-cdt. This result indicates that the higher the IUR is, the smaller the edema volume will be pre-cdt. Although there was a weak correlation between IUR and the volume reducing effect by six months, it is thought that this result was due to the smaller volume pre-cdt performed in patients with a higher IUR. We suggest that IUR is not a significant predictor of the outcome of CDT in lowerlimb lymphedema after surgery for gynecologic cancer. Our results indicated a significant, positive correlation between the EUR and percent excess volume in the proximal leg, distal leg, and whole leg pre-cdt. The EUR also correlated positively with the percent volume reduction in the distal leg immediately post-cdt, and at 3, 6, 12, and 24 months post-cdt, and in the whole leg immediately post-cdt, and at 3, and 6 months post-cdt. This indicates that the greater the edema volume pre-cdt is, the larger the dermal back flow will be on lymphoscintigraphy. As the EUR increased, the edema volume reduction in the distal leg was more pronounced by 24 months,
5 642 Y.B. Kim et al. / Gynecologic Oncology 127 (2012) and that of the whole leg was more pronounced by 6 months. Our study showed that only EUR among lymphoscintigraphic findings is a significant predictor on the outcome of CDT in lower-limb lymphedema after surgery for gynecologic cancer. Results of CR in the present study correspond with the results of earlier studies, which show that radioisotope clearance from the foot is not a reliable indicator and is less sensitive for the diagnosis of lymphatic impairment compared with lymph node uptake percentages [31,32]. The current investigation identified a role of lymphoscintigraphic imaging in predicting the initial volume at onset of lymphedema and the responsiveness of lymphedema to CDT. The main strengths of our study were that it was monocentric and dealt only with patients with unilateral lower-limb lymphedema occurring after surgery for gynecological cancer. This is also the largest study to date, comprising 158 patients followed over a period of two years. In conclusion, this study shows that the long-term edema reducing effect of CDT is well maintained for 24 months on whole leg, and is better maintained in the distal portion of the leg than in the proximal portion. Pre-treatment quantitative lymphoscintigraphy can help to predict the initial edema volume and therapeutic outcome in patients with lower-limb lymphedema and represents a potentially useful tool for the clinical assessment of lower-limb lymphedema. Conflict of interest statement The authors have nothing to disclose. Appendix A. Supplementary data Supplementary data to this article can be found online at dx.doi.org/ /j.ygyno References [1] Casley-Smith JR. Alterations of untreated lymphedema and its grades over time. Lymphology 1995;28: [2] Cheville AL, Almoza M, Courmier JN, Basford JR. A prospective cohort study defining utilities using time trade-offs and the Euroqol-5D to assess the impact of cancer-related lymphedema. Cancer 2010;116: [3] Szuba A, Rockson SG. Lymphedema: anatomy, physiology and pathogenesis. Vasc Med 1997;2: [4] Rainwater LM, Zincke H. Radical prostatectomy after radiation therapy for cancer of the prostate: feasibility and prognosis. J Urol 1988;140: [5] Petereit DG, Mehta MP, Buchler DA, Kinsella TJ. A retrospective review of nodal treatment for vulvar cancer. Am J Clin Oncol 1993;16: [6] Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002;9: [7] Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187: [8] Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM 2005;98: [9] McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol 2008;26: [10] Vignes S, Porcher R, Arrault M, Dupuy A. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat 2007;101: [11] Kim SJ, Yi CH, Kwon OY. Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral lymphedema. Lymphology 2007;40: [12] Hwang JH, Choi JY, Lee JY, Hyun SH, Choi Y, Choe YS, et al. Lymphoscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema. Lymphology 2007;40: [13] Hwang JH, Lee KW, Chang DY, Lee BB, Kim DI, Kim SJ, et al. Complex physical therapy for lymphedema. J Korean Acad Rehabil Med 1998;22: [14] Liao SF, Li SH, Huang HY. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of response to CDP in lower limb lymphedema (LLL) after pelvic cancer treatment. Gynecol Oncol 2012;125: [15] Pecking AP. Possibilities and restriction of isotopic lymphography for the assessment of therapeutic effects in lymphedema. Wien Med Wochenschr 1999;149: [16] Cambria RA, Gloviczki P, Naessens JM, Wahner HW. Noninvasive evaluation of the lymphatic system with lymphoscintigraphy: a prospective, semiquantitative analysis in 386 extremities. J Vasc Surg 1993;18: [17] Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 1988;167: [18] Ho LC, Lai MF, Yeates M, Fernandez V. Microlymphatic bypass in obstructive lymphoedema. Br J Plast Surg 1988;41: [19] Campisi C. Lymphoedema: modern diagnostic and therapeutic aspects. Int Angiol 1999;18: [20] Brorson H, Svensson H, Norrgren K, Thorsson O. Liposuction reduces arm lymphedema without significantly altering the already impaired lymph transport. Lymphology 1998;31: [21] Hwang JH, Kwon JY, Lee KW, Choi JY, Kim BT, Lee BB, et al. Changes in lymphatic function after complex physical therapy for lymphedema. Lymphology 1999;32: [22] Baulieu F, Baulieu JL, Secchi V, Dabiens J, Barsotti J, Itti R. Factorial analysis of dynamic lymphoscintigraphy in lower limb lymphoedema. Nucl Med Commun 1989;10: [23] Szuba A, Strauss W, Sirsikar SP, Rockson SG. Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity. Nucl Med Commun 2002;23: [24] Foldi E, Foldi M, Clodius L. The lymphedema chaos: a lancet. Ann Plast Surg 1989;22: [25] Casley-Smith JR. Modern treatment of lymphoedema. I. Complex physical therapy: the first 200 Australian limbs. Australas J Dermatol 1992;33:61-8. [26] Boris M, Weindorf S, Lasinski B, Boris G. Lymphedema reduction by noninvasive complex lymphedema therapy. Oncology (Williston Park) 1994;8: [discussion 9 10]. [27] Ko DS, Lerner R, Klose G, Cosimi AB. Effective treatment of lymphedema of the extremities. Arch Surg 1998;133: [28] Boris M, Weindorf S, Lasinkski S. Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology (Williston Park) 1997;11: [discussion 10, 13 4]. [29] Carena M, Campini R, Zelaschi G, Rossi G, Aprile C, Paroni G. Quantitative lymphoscintigraphy. Eur J Nucl Med 1988;14: [30] Ohtake E, Matsui K. Lymphoscintigraphy in patients with lymphedema. A new approach using intradermal injections of technetium-99m human serum albumin. Clin Nucl Med 1986;11: [31] Mostbeck A, Partsch H. Isotope lymphography possibilities and limits in evaluation of lymph transport. Wien Med Wochenschr 1999;149: [32] Partsch H. Assessment of abnormal lymph drainage for the diagnosis of lymphedema by isotopic lymphangiography and by indirect lymphography. Clin Dermatol 1995;13:
1. Skin care: Cleansing, lubrication, debriding and administration of antimicrobial therapy.
Lymphedema Treatment Last Review Date: October 13, 2017 Number: MG.MM.ME.05aC9 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider
More informationCHARACTERIZATION OF CONGENITAL VASCULAR MALFORMATION IN THE EXTREMITIES USING WHOLE BODY BLOOD POOL SCINTIGRAPHY AND LYMPHSCINTIGRAPHY
77 Lymphology 42 (2009) 77-84 CHARACTERIZATION OF CONGENITAL VASCULAR MALFORMATION IN THE EXTREMITIES USING WHOLE BODY BLOOD POOL SCINTIGRAPHY AND LYMPHSCINTIGRAPHY Y.H. Kim, J.Y. Choi, Y.W. Kim, D.I.
More information2007 ICL SHANGHAI 24/03/2013
Background Intradermal Lymphoscintigraphy: Technical Improvement and an Interpretation of the Pathological Patterns on Clinical Management of Severe Stage Lymphoedema. Girolamo Tartaglione, MD Department
More informationEFFICACY OF DECONGESTIVE THERAPY AND INTERMITTENT PNEUMATIC COMPRESSION IN PATIENTS WITH LYMPHEDEMA OF THE ARM AFTER BREAST CANCER TREATMENT
EFFICACY OF DECONGESTIVE THERAPY AND INTERMITTENT PNEUMATIC COMPRESSION IN PATIENTS WITH LYMPHEDEMA OF THE ARM AFTER BREAST CANCER TREATMENT Dragana Bojinović-Rodić MD, PhD Institute of Physical Medicine
More informationUtilizing Complete Decongestive Therapy to Treat Lymphedema: Evidence from Contemporary Literature
Vol. 25, No. 3 July - September 2013 Article Reprints Utilizing Complete Decongestive Therapy to Treat Lymphedema: Evidence from Contemporary Literature By: Kathryn McKillip Thrift, BS, CLT-LANA and DeCourcy
More informationThe Role of Radionuclide Lymphoscintigraphy in the Diagnosis of Lymphedema of the Extremities
The Role of Radionuclide Lymphoscintigraphy in the Diagnosis of Lymphedema of the Extremities Poster No.: C-1229 Congress: ECR 2014 Type: Authors: Keywords: DOI: Scientific Exhibit M. Osher 1, A. Pallas
More informationDiagnostic Accuracy of Lymphoscintigraphy for Lymphedema and Analysis of False-Negative Tests
Diagnostic Accuracy of Lymphoscintigraphy for Lymphedema and Analysis of False-Negative Tests The Harvard community has made this article openly available. Please share how this access benefits you. Your
More informationDifferentiation of High and Low Output Lymphatic Failure Using Qualitative Lymphangioscintigraphy
2015 Annals of Vascular Diseases doi:10.3400/avd.oa.15-00034 Original Article Differentiation of High and Low Output Lymphatic Failure Using Qualitative Lymphangioscintigraphy Kotaro Suehiro, MD, Noriyasu
More informationNEW CLINICAL AND LABORATORY STAGING SYSTEMS TO IMPROVE MANAGEMENT OF CHRONIC LYMPHEDEMA
122 Lymphology 38 (2005) 122-129 NEW CLINICAL AND LABORATORY STAGING SYSTEMS TO IMPROVE MANAGEMENT OF CHRONIC LYMPHEDEMA B.B. Lee, J.J. Bergan Department of Surgery (BBL), Uniformed Services University
More informationSubmitted by: Date of request: 28 th October 2015
Submitted by: Frank Vicini, MD, FACR Chief Medical Officer ImpediMed, Inc. 5900 Pasteur Court Suite 125 Carlsbad, CA 92008 Phone: 760 585 2100 Email: fvicini@impedimed.com Date of request: 28 th October
More informationLymphoscintigraphy of the Upper Extremities
Lymphoscintigraphy of the Upper Extremities MJ de Haas, Meander Medical Centre Amersfoort (Retired) 1. Introduction Lymphoedema is a chronic, progressive, and often debilitating condition. Primary lymphoedema
More informationDOES DEEP TISSUE MASSAGE HAVE AN IMPACT ON DIMENSION IN THE HIPS AND THIGHS?
DOES DEEP TISSUE MASSAGE HAVE AN IMPACT ON DIMENSION IN THE HIPS AND THIGHS? A Study Done By Charles W. Wiltsie III, LMT, NCBTMB INTRODUCTION Does deep tissue massage have an impact on the hips and thighs?
More informationRELATIONSHIP BETWEEN LYMPHOSCINTIGRAPHY AND CLINICAL FINDINGS IN LOWER LIMB LYMPHEDEMA (LO): TOWARD A COMPREHENSIVE STAGING
1 Lymphology 41 (2008) 1-10 RELATIONSHIP BETWEEN LYMPHOSCINTIGRAPHY AND CLINICAL FINDINGS IN LOWER LIMB LYMPHEDEMA (LO): TOWARD A COMPREHENSIVE STAGING A.P. Pecking, J.L. Albérini, M. Wartski, V. Edeline,
More informationTHE ROLE OF LYMPHOSCINTIGRAPHY IN THE DIAGNOSIS OF LYMPHEDEMA IN TURNER SYNDROME
123 Lymphology 42 (2009) 123-129 THE ROLE OF LYMPHOSCINTIGRAPHY IN THE DIAGNOSIS OF LYMPHEDEMA IN TURNER SYNDROME C. Bellini, E. Di Battista, F. Boccardo, C. Campisi, G. Villa, G. Taddei, C. Traggiai,
More informationCatherine Holley, RN Operating Room Nurse Massachusetts General Hospital
Operating Room Nurse Massachusetts General Hospital March 13, 2019 What is Lymphedema? Swelling (edema) that occurs due to injury or impairment of the lymphatic system Causes: Anything that disrupts the
More informationThe Standard of Care for Lymphedema: Current Concepts and Physiological Considerations
The Standard of Care for Lymphedema: Current Concepts and Physiological Considerations Harvey N. Mayrovitz PhD Professor of Physiology College of Medical Sciences Nova Southeastern University mayrovit@nova.edu
More informationResearch Report. Measurement Decisions for Clinical Assessment of Limb Volume Changes in Patients With Bilateral and Unilateral Limb Edema
Research Report Measurement Decisions for Clinical Assessment of Limb Volume Changes in Patients With Bilateral and Unilateral Limb Edema Harvey N Mayrovitz, John Macdonald, Suzanne Davey, Kelly Olson,
More informationManagement of Lower Limb Lymphoedema in the United Kingdom
Eur J Vasc Endovasc Surg 31, 311 315 (6) doi:1.116/j.ejvs.5.9.17, available online at http://www.sciencedirect.com on Management of Lower Limb Lymphoedema in the United Kingdom A. Tiwari, F. Myint and
More informationREVIEW. Arm Edema in Breast Cancer Patients. Virginia S. Erickson, Marjorie L. Pearson, Patricia A. Ganz, John Adams, Katherine L.
REVIEW Arm Edema in Breast Cancer Patients Virginia S. Erickson, Marjorie L. Pearson, Patricia A. Ganz, John Adams, Katherine L. Kahn The improvement in the life expectancy of women with breast cancer
More informationWhen is it lymphedema, when is it not lymphedema? UNDERSTANDING EDEMA. John Mulligan, RMT/CLT-LANA
When is it lymphedema, when is it not lymphedema? UNDERSTANDING EDEMA John Mulligan, RMT/CLT-LANA Learning Objectives How to identify stages of lymphedema The Gold Standard of Treatment for Lymphedema
More informationCLASSIFICATION OF LYMPHOSCINTIGRAPHY AND RELEVANCE TO SURGICAL INDICATION FOR LYMPHATICOVENOUS ANASTOMOSIS IN UPPER LIMB LYMPHEDEMA
155 Lymphology 44 (2011) 155-167 CLASSIFICATION OF LYMPHOSCINTIGRAPHY AND RELEVANCE TO SURGICAL INDICATION FOR LYMPHATICOVENOUS ANASTOMOSIS IN UPPER LIMB LYMPHEDEMA T. Mikami, M. Hosono, Y. Yabuki, Y.
More informationPRESOR-03 STUDY ON THE EFFECTIVENESS OF USING THE SORISA PRESSURE THERAPY
PRESOR-03 STUDY ON THE EFFECTIVENESS OF USING THE SORISA PRESSURE THERAPY CONTENTS 1.0. PRESSURE THERAPY 1.1. The physiological effects of pressure therapy 1.2. When pressure therapy is indicated 2.0.
More informationUltrasonographic Evaluation of the Effects of Progressive Resistive Exercise in Breast Cancer-Related Lymphedema
LYMPHATIC RESEARCH AND BIOLOGY Volume 14, Number 1, 2016 ª Mary Ann Liebert, Inc. DOI: 10.1089/lrb.2015.0021 Ultrasonographic Evaluation of the Effects of Progressive Resistive Exercise in Breast Cancer-Related
More informationCatherine Holley, RN Operating Room Nurse Massachusetts General Hospital
Operating Room Nurse Massachusetts General Hospital March 15, 2017 Background Nurse 34 years Operating room RN at Massachusetts General Hospital 1979 surgery to remove varicose veins right leg Strong family
More informationRisk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer
HEALTH SERVICES RESEARCH FUND Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer Key Messages 1. Previous inflammation or infection of
More informationLymphedema Myths Realities - Hope
Lymphedema Myths Realities - Hope Texas Health Presbyterian Hospital of Dallas Lymphedema Therapy Department 214-345-7680 Lymphatic System Divided into sections - watersheds Lymph nodes act as filtration
More informationLEVEL ONE COURSE CONTENT
LEVEL ONE COURSE CONTENT Dear Health Practitioner, The level one lymphoedema training course offered by the ALERT program at Macquarie University is open to AHPRA registered health professionals only (such
More informationCancer Support V.I. Presents
Cancer Support V.I. Presents Overview & Discussion of Manual Lymph Drainage/Complete Decongestive Therapy (MLD/CDT) Presented by: Christopher A. Borgesen, MS,OTR September 3 rd, 2008 Christopher A. Borgesen,
More informationLYMPHEDEMA GOALS FOR TODAY WELL-INTENTIONED, BUT. the more you know TEDS. Diuretics. Prescribe compression garments without first reducing edema
LYMPHEDEMA the more you know GOALS FOR TODAY WELL-INTENTIONED, BUT TEDS Recognize full Continuum of Lymphedema stages Identify Range of Lymphedema Diagnoses Differentiate Effective Treatment Options from
More informationCASE REPORT Blocking of the Lymphatic Vessel in Lymphedema
CASE REPORT Blocking of the Lymphatic Vessel in Lymphedema Hisako Hara, MD, and Makoto Mihara, MD Department of Lymphatic and Reconstructive Surgery, Saiseikai Kawaguchi General Hospital, Saitama, Japan
More informationPopliteal Node Visualization During Standard Pedal Lymphoscintigraphy for a Swollen Limb Indicates Impaired Lymph Drainage
Nuclear Medicine and Molecular Imaging Original Research Burnand et al. Popliteal Nodes in Lymphoscintigraphy Nuclear Medicine and Molecular Imaging Original Research Katherine M. Burnand 1 Daphne M. Glass
More informationSUCTION ASSISTED PROTEIN LIPECTOMY (SAPL) EVEN FOR THE TREATMENT OF CHRONIC FIBROTIC AND SCARIFIED LOWER EXTREMITY LYMPHEDEMA
36 Lymphology 49 (2016) 36-41 SUCTION ASSISTED PROTEIN LIPECTOMY (SAPL) EVEN FOR THE TREATMENT OF CHRONIC FIBROTIC AND SCARIFIED LOWER EXTREMITY LYMPHEDEMA M. Lee, L. Perry, J. Granzow Emory University
More informationAustin Radiological Association Nuclear Medicine Procedure LYMPHOSCINTIGRAPHY (Tc-99m-Sulfur Colloid [Filtered])
Austin Radiological Association Nuclear Medicine Procedure LYMPHOSCINTIGRAPHY (Tc-99m-Sulfur Colloid [Filtered]) Overview Indications The Lymphoscintigraphy Study demonstrates the flow of lymph from the
More informationA review of lymphoscintigraphy - what constitutes a positive result and how this affects the patients management.
A review of lymphoscintigraphy - what constitutes a positive result and how this affects the patients management. Poster No.: C-1030 Congress: ECR 2014 Type: Educational Exhibit Authors: N. J. Ley, E.
More informationMagnetic Resonance Lymphangiography for the Study of Lymphatic System in Lymphedema
66 Invited Review Magnetic Resonance Lymphangiography for the Study of Lymphatic System in Lymphedema NingFei Liu, MD, PhD 1 Yixin Zhang, MD, PhD 1 1 Department of Plastic and Reconstructive Surgery, Shanghai
More informationCaresiaTM. Off-the-Shelf Bandage Liners
CaresiaTM M A N U F A C T U R E D B Y S O L A R I S Off-the-Shelf Bandage Liners Table of Contents 2 3 4 6 8 10 11 Contact Information About Caresia Upper Extremity Garments Lower Extremity Garments Donning
More informationMICROSURGERY. Predictive Lymphatic Mapping
MICROSURGERY A Method for Mapping Lymphatic Channels in Patients With Advanced Unilateral Lymphedema Using Indocyanine Green Lymphography Makoto Mihara, MD,* Yukio Seki, MD,* Hisako Hara, MD,* Takuya Iida,
More informationAxillary Reverse Mapping to Reduce the Incidence of Lymphedema
Axillary Reverse Mapping to Reduce the Incidence of Lymphedema Nathalie Johnson,MD,FACS Medical Director, Legacy Cancer Institute and Breast Health Centers Portland,Oregon Objectives for Learning Understand
More information9 Day Certified Lymphedema & Wound Therapist (62.5 CE hrs On-line + 9 Days Live Training (8am 8pm *daily times vary; 153 CE hrs Total!
1 9 Day Certified Lymphedema & Wound Therapist (62.5 CE hrs On-line + 9 Days Live Training (8am 8pm *daily times vary; 153 CE hrs Total!) On-Line COURSE OUTLINE/Overview of Topics (62.5hrs): Lymphatics
More informationLYMPHOEDEMA FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE
LYMPHOEDEMA FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE PROFESSOR OF SURGERY & DIRECTOR, PROFESSIONAL DEVELOPMENT CENTRE J I N N A H S I N D H M E D I C A L U N I V E R S I T Y
More informationMedical Policy Original Effective Date: 01/23/2019
Page 1 of 12 Disclaimer Refer to the member s specific benefit plan and Schedule of Benefits to determine coverage. This may not be a benefit on all plans or the plan may have broader or more limited benefits
More informationA NOVEL, VALIDATED METHOD TO QUANTIFY BREAST CANCER-RELATED LYMPHEDEMA (BCRL) FOLLOWING BILATERAL BREAST SURGERY
64 Lymphology 46 (2013) 64-74 A NOVEL, VALIDATED METHOD TO QUANTIFY BREAST CANCER-RELATED LYMPHEDEMA (BCRL) FOLLOWING BILATERAL BREAST SURGERY C.L. Miller, M.C. Specht, N. Horick, M.N. Skolny, L.S. Jammallo,
More informationInterest of an auto-adjustable nighttime compression sleeve (MOBIDERM Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT
Support Care Cancer (2017) 25:2455 2462 DOI 10.1007/s00520-017-3652-5 ORIGINAL ARTICLE Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM Autofit) in maintenance phase of upper limb
More informationVascularized Lymph Node Transfer From Thoracodorsal Axis for Congenital and Post Filarial Lymphedema of the Lower Limb
CASE REPORT Vascularized Lymph Node Transfer From Thoracodorsal Axis for Congenital and Post Filarial Lymphedema of the Lower Limb HARI VENKATRAMANI, MCh, DNB, EDHS,* SENTHIL KUMARAN, MCh, SHIVANNAIAH
More informationRobert Harris, Neil Piller
MANUAL LYMPHATIC DRAINAGE RESEARCH Three case studies indicating the effectiveness of manual lymph drainage on patients with primary and secondary lymphedema using objective measuring tools... Robert Harris,
More informationTreatment of lymphoedema surgical and conservative approaches
Treatment of lymphoedema surgical and conservative approaches Nina Linnitt RN Clinical Manager medi UK Current Chair British Lymphology Society (BLS) What is lymphoedema? International Societie de Lymphologue
More informationInvestigation of lymphatic edema requires a reliable
Quantification of Lymphatic Function for Investigation of Lymphedema: Depot Clearance and Rate of Appearance of Soluble Macromolecules in Blood Simon J. Pain, MA 1 ; R. Steven Nicholas, PhD 2 ; Robert
More informationEfficacy and patient satisfaction regarding lymphovenous bypass with sleeve-in anastomosis for extremity lymphedema
Efficacy and patient satisfaction regarding lymphovenous bypass with sleeve-in anastomosis for extremity lymphedema Original Article Jae-Ho Chung, Si-Ook Baek, Ho-Jin Park, Byung-Il Lee, Seung-Ha Park,
More informationVenous Insufficiency Ulcers. Patient Assessment: Superficial varicosities. Evidence of healed ulcers. Dermatitis. Normal ABI.
Venous Insufficiency Ulcers Patient Assessment: Superficial varicosities Evidence of healed ulcers Dermatitis Normal ABI Edema Eczematous skin changes 1. Scaling 2. Pruritus 3. Erythema 4. Vesicles Lipodermatosclerosis
More information90% [1] / index.php / kfxb , * (2015ZB040) DOI: / SP.J
2017 27 6 www.sciencemeta.com / index.php / kfxb 1 12* 1 200040; 2 200040 * : E-mail:shannonjj@126.com :2017-10-02; :2017-11-26 : (2015ZB040) ; ; 16.9 30 5 5 5 90% [1] [2] [7] 50% [3] 1.2 1 [4] [5] [8]
More information4. WHY a Lymphovenous anastomosis can be indicated in Lymphedema?
LYMPHOVENOUS ANASTOMOSIS TECHNIQUE ( LVA / MLVA / MLVLA ). Alessandro Busetto Wolfsberg March 20-21, 2018 1. Speaer s agreement 2. Title. The aim of our communication is to describe and compare the various
More informationGUIDELINES FOR SELF MANAGEMENT OF LYMPHOEDEMA. Nicole L. Stout DPT, CLT-LANA,
GUIDELINES FOR SELF MANAGEMENT OF LYMPHOEDEMA Nicole L. Stout DPT, CLT-LANA, FAPTA nicole.stout@nih.gov @nicolestoutpt Self Management in Lymphedema Prevention and Risk Reduction Secondary Lymphedema
More informationWelcome to Allied Health Telehealth
Welcome to Allied Health Telehealth Paediatric lymphoedema A challenge for clinicians and families To receive an attendance certificate please complete your online evaluation at: https://www.surveymonkey.com/s/paedlymphoedema
More informationALTHOUGH ONE in 30 persons worldwide has LE, 1 management
756 ORIGINAL ARTICLE Assessment of Lymphatic Contractile Function After Manual Lymphatic Drainage Using Near-Infrared Fluorescence Imaging I-Chih Tan, PhD, Erik A. Maus, MD, John C. Rasmussen, PhD, Milton
More informationDOI: /caac This information is current as of January 15, 2009
Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment Brian D. Lawenda, Tammy E. Mondry and Peter A. S. Johnstone CA Cancer J Clin 2009;59;8-24 DOI: 10.3322/caac.20001
More informationLymphedema: Early Detection and Quantitative Assessment
Lymphedema: Early Detection and Quantitative Assessment Harvey N. Mayrovitz PhD Professor of Physiology College of Medical Sciences Nova Southeastern University mayrovit@nova.edu Lymphedema Physiology
More informationThe impact of Lymphedema on occupational performance, an opportunity for Occupational Therapy. Byron Shier, MBA, B.Sc. OT, CLT-LANA, CHE.
The impact of Lymphedema on occupational performance, an opportunity for Occupational Therapy Byron Shier, MBA, B.Sc. OT, CLT-LANA, CHE. CLR Healthcare Inc. Presentation at 2013 Canadian Association of
More informationOriginal article. Keywords: Lymphoscintigraphy Lymphoedema Leg oedema Technetium-99m human serum albumin Lymphatic flow
Original article Assessment of leg oedema by dynamic lymphoscintigraphy with intradermal injection of technetium-99m human serum albumin and load produced by standing Kazuyoshi Suga, Norihiko Kume, Naofumi
More informationPriorities Forum Statement
Priorities Forum Statement Number 5 Subject Lymphoedema Date of decision November 2015 Date refreshed March 2017 Date of review November 2018 GUIDANCE Lymphoedema is the result of accumulation of fluid
More informationUse of a velcro wrap system in the management of lower limb lymphoedema/chronic oedema. Sue Lawrance
Use of a velcro wrap system in the management of lower limb lymphoedema/chronic oedema Sue Lawrance Abstract Lymphoedema and chronic lower limb oedema are conventionally treated with multi-layer bandaging,
More information5/28/ Memorial Sloan-Kettering Cancer Center, All Rights Reserved Memorial Sloan-Kettering Cancer Center, All Rights Reserved.
Sillerman Center for Rehabilitation The presenters have no conflict of interest to report regarding any commercial product/manufacturer that may be referenced during this presentation. 1 Key components
More informationExpanding Lymphedema Prevention and Management Programs in Rural Health and Third World Countries: A Capstone Presentation
Expanding Lymphedema Prevention and Management Programs in Rural Health and Third World Countries: A Capstone Presentation By: Cally Tejkl Pacific University July 2014 Objectives Define lymphedema Explain
More informationLymphoedema Level One Course Content
Lymphoedema Level One Course Content Dear Health Practitioner, The Level One lymphoedema training course offered by the ALERT Education at Macquarie University is open to AHPRA registered health professionals
More informationBreast Cancer Treatment and Lymphedema
Breast Cancer Treatment and Lymphedema Over the last decade, major advances have been made in the prevention and treatment of breast cancer in the United States, but minimal attention has been given to
More informationPractice of Axilla Surgery
Summer School of Breast Disease 2016 Practice of Axilla Surgery Axillary Lymph Node Dissection & Sentinel Lymph Node Biopsy 연세의대외과 박세호 Contents Anatomy of the axilla Axillary lymph node dissection (ALND)
More informationLYMPHATIC CLEARANCE OF THE HUMAN SKIN IN PATIENTS WITH ACUTE DEEP VEIN THROMBOSIS USING A NOVEL FLUORESCENT TECHNIQUE
127 Lymphology 39 (2006) 127-131 LYMPHATIC CLEARANCE OF THE HUMAN SKIN IN PATIENTS WITH ACUTE DEEP VEIN THROMBOSIS USING A NOVEL FLUORESCENT TECHNIQUE M.J. Husmann, R. Simon. T. Kovacevic, G. Gitzelmann,
More informationAppropriate Concept of Prevention of Lymphedema at the Initial Treatment
Global Breast Cancer Conference 2018 Appropriate Concept of Prevention of Lymphedema at the Initial Treatment Zisun Kim Department of Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationLymphoedema following treatment for breast cancer: a new approach to an old problem
Lymphoedema following treatment for breast cancer: a new approach to an old problem Screening breast cancer patients for lymphoedema makes it possible to identify problems early and take action to halt
More informationLymphatic Research and Biology. Lymphatic Research and Biology:
Lymphatic Research and Biology Lymphatic Research and Biology: http://mc.manuscriptcentral.com/lymphatic The Standard of Care for Lymphedema: Current Concepts and Physiological Considerations Journal:
More informationPreoperative upper limb lymphatic function in breast cancer surgery
ORIGINAL ARTICLE Preoperative upper limb lymphatic function in breast cancer surgery LAURA FERREIRA DE REZENDE 1, FELIPE VILELA PEDRAS 2, CELSO DARIO RAMOS 3, MARIA SALETE COSTA GURGEL 4 1 Post-doctorate,
More informationLymphoscintigraphy to confirm the diagnosis of lymphedema
Lymphoscintigraphy to confirm the diagnosis of lymphedema clinical Peter J. Golueke, MD, Robert A. Montgomery, MD, John D. Petronis, MD,* Stanley L. Minken, MD, Bruce A. Perler, MD, and G. Melville Williams,
More informationREPEATED INTRANODAL LYMPHANGIOGRAPHY FOR THE TREATMENT OF LYMPHATIC LEAKAGE
59 Lymphology 48 (2015) 59-63 REPEATED INTRANODAL LYMPHANGIOGRAPHY FOR THE TREATMENT OF LYMPHATIC LEAKAGE S. Kariya, M. Nakatani, R. Yoshida, Y. Ueno, A. Komemushi, N. Tanigawa Department of Radiology,
More informationCASE STUDY. Potential conflict of interest:
CASE STUDY presented by MICHEL EID, Lymphedema therapist Vodder School Teacher Physio Extra 2014 1 Potential conflict of interest: Invited speaker for: Physio Extra Jobst Medi Valco 1 What is lymphedema?
More informationBreast Imaging. Jamie L. Wagner, DO, FACOS. Digital vs Analog Mammography (2-D) Surgical Oncologist. Patient with Cancer. Radiology/ Interventional
Breast Cancer Prevention, Treatment, and Survivorship Jamie L. Wagner, DO, FACOS Assistant Professor Chief, Division of Breast Surgery Department of Surgery Anesthesiology Surgical Oncologist Patient with
More informationThe Lymphatic System. Oedema (Edema) Lymphoedema (Lymphedema)
The Lymphatic System The lymphatic system is similar to the blood system and has just as many vessels - but they contain lymph, which is clear and so cannot be seen (unless a suitable dye is injected).
More informationSimulated Manual Lymph Drainage Therapy in Home Treatment of Lymphedema
Simulated Manual Lymph Drainage Therapy in Home Treatment of Lymphedema Kenneth Dedeker, M.D., Irene Waldridge, CMT, MLD/CDPT ABSTRACT Background Lymphedema is a chronic, debilitating disease of the lymphatic
More informationLymphedema 101. Andréa Leiserowitz, DPT, CLT. Oncology Physical Therapy;
Lymphedema 101 Andréa Leiserowitz, DPT, CLT Oncology Physical Therapy; oncologypt@gmail.com Note: this information is the property of Dr. Leiserowitz and should not be copied, distributed, or otherwise
More informationCOURSE INFORMATION. Professional Training in the Original Dr. Vodder Method of Manual Lymph Drainage (MLD) and Combined Decongestive Therapy (CDT)
Professional Training in the Original Dr. Vodder Method of Manual Lymph Drainage (MLD) and Combined Decongestive Therapy (CDT) Post Graduate Certificate in MLD & CDT COURSE INFORMATION Jan Douglass CONTENTS
More informationLYMPHATIC DRAINAGE IN THE BREAST BEFORE AND UP TO FIVE YEARS AFTER A REDUCTION MAMMAPLASTY
157 Lymphology 49 (2016) 157-164 LYMPHATIC DRAINAGE IN THE BREAST BEFORE AND UP TO FIVE YEARS AFTER A REDUCTION MAMMAPLASTY L. Zetterlund, R. Axelsson, L. Svensson, L. Perbeck, F. Celebioglu Department
More informationAXILLARY WEB SYNDROME AFTER LYMPH NODE DISSECTION: RESULTS OF 1,004 BREAST CANCER PATIENTS
ARTIGO PUBLICADO: Bergmann A; Mattos IE; Koifman RJ; Ribeiro MJ; gueira EA, Ribeiro EP; Marchon RM; Maia AV; Roberto DR; Pereira TB; Santos IV; Viana FV; Magno J; Gonçalo AC. Axillary web syndrome after
More informationSentinel Lymph Node Biopsy Is Valuable For All Cancer. Surgery Grand Rounds Debate October 6, 2008 Joel Baumgartner
Sentinel Lymph Node Biopsy Is Valuable For All Cancer Surgery Grand Rounds Debate October 6, 2008 Joel Baumgartner History Lymphatics first described by Rasmus Bartholin in 1653 Rudolf Virchow postulated
More informationMelanoma Quality Reporting
Melanoma Quality Reporting September 1, 2013 December 31, 2016 Laurence McCahill, MD Surgical Oncologist Metro Health Surgical Oncology Metro Health Professional Building 2122 Health Drive SW Wyoming,
More informationRole of Physical Therapists in the Treatment of Lymphedema
October 19, 2009 Medical Evidence Development and Coverage Advisory Committee (MEDCAC) Centers for Medicare & Medicaid Services (CMS) Office of Clinical Standards and Quality, Coverage & Analysis Group
More informationLymphoscintigraphy is a special type of nuclear medicine imaging that provides pictures called scintigrams of the lymphatic system.
Scan for mobile link. Lymphoscintigraphy Lymphoscintigraphy helps evaluate your body s lymphatic system for disease using small amounts of radioactive materials called radiotracers that are typically injected
More informationA Pilot, Prospective Evaluation of a Novel Alternative For Maintenance Therapy of Breast Cancer-Associated Lymphedema [ISRCTN ]
BMC Cancer This Provisional PDF corresponds to the article as it appeared upon acceptance. The fully-formatted PDF version will become available shortly after the date of publication, from the URL listed
More informationBMC Cancer. Open Access. Abstract. BioMed Central
BMC Cancer BioMed Central Research article A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412] Olivia Wilburn, Paul Wilburn
More informationTc-99m-Human Serum Albumin Transit Time as a Measure of Arm Breast Cancer- Related Lymphedema
Syddansk Universitet Tc-99m-Human Serum Albumin Transit Time as a Measure of Arm Breast Cancer- Related Lymphedema Toyserkani, Navid M; Hvidsten, Svend; Tabatabaeifar, Siavosh; Simonsen, Jane Angel; Høilund-Carlsen,
More informationRadionuclide detection of sentinel lymph node
Radionuclide detection of sentinel lymph node Sophia I. Koukouraki Assoc. Professor Department of Nuclear Medicine Medicine School, University of Crete 1 BACKGROUND The prognosis of malignant disease is
More informationA Proposed Exercise Pathway for Recovery. Enhancing the lymphatics during recovery. Understand how exercise can enhance lymphatic function
A Proposed Exercise Pathway for Recovery Enhancing the lymphatics during recovery Review of the Lymphatic System Understand how exercise can enhance lymphatic function Finding your limits Evidence-based
More informationWhat is Lymphedema? Primary lymphedema: a person is born with the condition where the lymphatic vessels are not formed completely or malformed
Lymphedema What is Lymphedema? Lymphedema is a chronic health condition which causes localized swelling. There are 2 types: Primary lymphedema: a person is born with the condition where the lymphatic vessels
More informationlymphedema management the comprehensive guide for practitioners 2nd edition complementary medicine thieme hardcover
DOWNLOAD OR READ : LYMPHEDEMA MANAGEMENT THE COMPREHENSIVE GUIDE FOR PRACTITIONERS 2ND EDITION COMPLEMENTARY MEDICINE THIEME HARDCOVER PDF EBOOK EPUB MOBI Page 1 Page 2 hardcover lymphedema management
More informationPosition Statement on Management of the Axilla in Patients with Invasive Breast Cancer
- Official Statement - Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer Sentinel lymph node (SLN) biopsy has replaced axillary lymph node dissection (ALND) for the
More informationMEASUREMENT OF SOFT TISSUE COMPLIANCE WITH PRESSURE USING ULTRASONOGRAPHY
167 Lymphology 41 (2008) 167-177 MEASUREMENT OF SOFT TISSUE COMPLIANCE WITH PRESSURE USING ULTRASONOGRAPHY W. Kim, S.-G. Chung, T.-W. Kim, K.-S. Seo Department of Rehabilitation Medicine (WK, S-GC, K-SS),
More informationRelation between the Peripherofacial Psoriasis and Scalp Psoriasis
pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 28, No. 4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.422 ORIGINAL ARTICLE Relation between the Peripherofacial Psoriasis and Scalp Psoriasis Kyung Ho
More informationMedical Policy. MP Surgical Treatments for Breast Cancer-Related Lymphedema
Medical Policy MP 7.01.162 Surgical Treatments for Breast Cancer-Related Lymphedema BCBSA Ref. Policy: 7.01.162 Last Review: 07/25/2018 Effective Date: 10/30/2018 Section: Surgery Related Policies 1.01.18
More informationSentinel Lymph Node Biopsy for Breast Cancer
Sentinel Lymph Node Biopsy for Breast Cancer Registrar Tutorial Adam Cichowitz Surgical Registrar The Royal Melbourne Hospital Sentinel Lymph Node Biopsy Axillary LN status important prognostic factor
More informationFeasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients before Neoadjuvant Chemotherapy: A Preliminary Study
[ABS-0078] GBCC 2018 Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients before Neoadjuvant Chemotherapy: A Preliminary Study Eun Young Kim 1, Kwan Ho Lee 1, Yong
More informationNoninvasive evaluation of the swollen extremity: Experiences with 190 lymphoscintigraphic examinations.
Noninvasive evaluation of the swollen extremity: Experiences with 190 lymphoscintigraphic examinations. Peter Gloviczki, M_D, David Calcagno, MD, Alexander Schirger, MD, Peter C. Pairolero, MD, Kenneth
More information